Market Research Blog – Page 9834 – New Product Development

Anti-counterfeit Pharmaceutical Packaging Market Size & Share | Global Industry Report for 2027

A new market research report by FMI on the anti-counterfeit pharmaceutical packaging market includes global industry analysis 2014–2021 and opportunity assessment 2022–2027. The report analyses the anti-counterfeit pharmaceutical packaging market and provides critical insights for the forecast period 2022-2027. As per findings of the report, the global anti-counterfeit pharmaceutical packaging market is projected to experience a significant growth over the forecast period due to multiple driving factors.

The market for anti-counterfeit pharmaceutical packaging is anticipated to expand lavishly between 2022 and 2027 at a CAGR of 8.4%. By 2027, it might total US$ 149.1 billion.

The global sales of the anti-counterfeit pharmaceutical packaging market is estimated to be valued at ~ US$ 77 Bn in 2019, which translates into an opportunity worth of ~US$ 3.5 Bn for anti-counterfeit technology for pharmaceuticals.

Request a Sample Report with Table of Contents @ http://www.futuremarketinsights.com/reports/sample/rep-gb-2385

Developing Economies to Hold Promising Investment Opportunities during the Forecast Period

China & Japan cumulatively account for more than half of the total Asia Pacific anti-counterfeit pharmaceutical packaging market. This is accredited to the fastest-growing pharmaceutical market, particularly on the back of increasing number of population, coupled with rising regulations in pharmaceutical sector of China and India. The economical manufacturing environment and developing economy are vital factors driving the anti-counterfeit pharmaceutical packaging market in the APAC region.

Growing penetration of local manufacturers in their respective regions also fuels the anti-counterfeit pharmaceutical packaging market growth in the region. Furthermore, developing economies of Latin America such as Mexico and Argentina are expected to have potential in the anti-counterfeit pharmaceutical packaging market during the forecast period. Illegal sale of pharmaceutical drugs is a growing concern, most particularly in developing countries of Latin America where the lack of healthcare concern forces people to seek cheaper drugs.

This is hamstringing the anti-counterfeit pharmaceutical packaging market growth. In the absence of effective system and regulations, the market of counterfeit drugs and other medical supplies has been increased. Also, semi-legal copying of branded drugs by legitimate local companies would remain a high-profile problem. All these factors will create an impact on the growth of the anti-counterfeit pharmaceutical packaging in the coming years.

Get In Touch With Our Team For 20% Flat Discount:

Approach towards Electronic Track and Trace to Secure the Supply of Drugs

For secure supply of drugs from manufacturers to end users, one of the key requirements is the ability to trace, validate, and verify the authenticity of the drug at each and every stage of the supply chain. It is expected to boost the demand for anti-counterfeit pharmaceutical packaging in the near future. In electronic track and trace technology, each unit is serialized and allows building the drug pedigree.

These pedigrees include information about manufacturers, distributors, and wholesalers who handles the drug. This helps in tracing the product at any stage and reduces counterfeiting, which stimulates the anti-counterfeit pharmaceutical packaging market growth.

Increased Number of Self-prescribed Patients Opting for Less Expensive Pharma Products

~ 5% of the U.S adults are using medication without any professional prescription. Increase in number of self-prescribed patients is hampering the anti-counterfeit pharmaceutical packaging market. Sometimes, end users of pharma products opt for counterfeit products, as they are less expensive compared to the original medications. This perception of patients is restraining the anti-counterfeit pharmaceutical packaging market growth.

Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-2385

Global Anti-Counterfeit Pharmaceutical Packaging Market: Competitive Landscape

Anti-counterfeit pharmaceutical packaging manufacturers have taken steps to tackle the menace of counterfeited medicines through innovative packaging techniques, which is still in the infancy stage but future looks promising. Advancement in technology is expected to spur the demand for anti-counterfeit pharmaceutical packaging products. Large pharmaceutical companies such as Pfizer and GlaxoSmithKline have introduced RFID tags on the packaging of Viagra and Trizivir, an HIV treatment product, which is driving the anti-counterfeit pharmaceutical packaging market growth.

Some of the key players in the global anti-counterfeit pharmaceutical packaging market are Alien Technology, ATL Security Label Systems, CCL Industries, SICPA Holdings, Schott AG, Gerresheimer AG, Klockner Pentaplast Group, Ardagh Group S.A., Nipro Corporation, Authentix Inc., TruTag Technologies, Inc., Zebra Technologies Corporation, Alpvision SA, OpSec Security Inc., Savi Technology Inc., 3M, and Stevanato Group.

About Packaging Division at Future Market Insights

The Packaging division at FMI provides an in-depth historical analysis and granular projections of the global packaging market. Ranging from packaging materials to designs & formats, FMI has an exhaustive market research database, serving clients with unique offerings and strategic recommendations. With a repository of 750+ reports, the team analyzed the packaging industry comprehensively in 70+ countries. The team evaluates every node of the value chain and provides end-to-end research and consulting services; reach out to explore how we can help

Key Segments Covered in Anti-Counterfeit Pharmaceutical Packaging Industry Research

By Packaging Format :

Bottles & Jars
Vials & Ampoules
Blisters
Trays
Pouches & Sachets
Others (Tubes, Syringes, etc.)

By Printing Technology :

RFID
Security Inks & Coatings
Security Seals
Holograms
Mass Encryption
Barcode
Mass Serialization

By Adhesion :

Permanent
Removable
Repositionable

By End-application :

Pharma & Biological
Medical & Supplies
Gloves
Scissors
Syringes & Needles
Surgical Tapes
Others
Medical Equipment
Surgical
Therapeutic
Diagnostic

https://stemfemmes.mn.co/posts/24948995?utm_source=manual

https://careero.mn.co/posts/24949001?utm_source=manual

https://thegameoflife-de.mn.co/posts/24949002?utm_source=manual

https://network-66643.mn.co/posts/24949004?utm_source=manual

About FMI
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 5-years.

Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

North America’s Fresh Meat Packaging Market is poised to showcase elevated demand for fresh meat packaging from 2021 to 2031

The North America fresh meat packaging market is expected to grow at 3.1% CAGR surpassing the market valuation of US$ 788 million in 2021. The growth can be attributed to availability of customization in clear meat packaging and high demand for convenient packaging solutions among urban population. Future Market Insights (FMI) predicts that fresh meat packaging market sales will surpass 365,800 tons in North America by the end of 2021.

Competitive Landscape

Future Market Insights in its latest market analysis discusses about the key trends shaping the fresh meat packaging market and highlights the strategies employed by market players to strengthen their market position. Market players are emphasizing on expanding their product portfolio to reach wider customer base. They are also inclined towards forming alliance and strategic merger and acquisition with other players.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-na-1517

For instance, in April 2021, Coveris Holdings S.A. completed the acquisition of a profitable and stable business Initial Packaging Ltd which specialized in the production of specialty bags to focus on converted high end packaging solutions

At film convertor level

Bemis Company, Inc.,
Winpak Ltd.,
Sealed Air Corp.,
Berry Plastic Group, Inc.,
Coveris Holdings S.A.

At packaging equipment manufacturers level

Multivac Sepp Haggenmüller GmbH & Co.KG
Robert Reiser & Co
Harpak-ULMA Packaging, LLC
ALKAR-RapidPak, Inc.
Sealpac International BV.

At meat producer level

Tyson Foods, Inc.
JBS SA ADR
Cargill Meat Solutions Corporation
National Beef Packing Company, LLC.
Hormel Foods Corporation

At the retailer level

Wal-Mart Stores, Inc.
The Kroger Co.
Costco Wholesale Corporation
Whole Foods Market IP. L.P.
Wegmans Food Markets Inc.

Competition in the North America market for fresh meat packaging is expected soar. FMI however forecasts Berry Global Group Inc., Amcor Plc, Sealed Air Corp., Bolloré Group, and Winpak Ltd. to remain dominant, accounting for nearly 15% to 20% of overall sales registered in 2021.

Get In Touch With Our Team For 20% Flat Discount:

Market players are looking towards integrating recycled material in fresh meat packaging to replace the packaging solutions containing polystyrene foam tray and plastic film.

Growing consumer awareness and concern for non-biodegradable plastic has pushed market payers towards producing bio-plastics and molded fiber materials in compliance with performance requirements and standards set in packaging to keep the meat fresh for consumption.

Increasing consumption of animal meat especially poultry, pork, and beef in U.S. and Canada will boost the demand for fresh meat packaging solutions during the forecast period. Rapid urbanization and improved standard of living are the key factors directly influencing the consumption of animal products in these countries.

More than 354 million chickens were slaughtered in federally inspected slaughter houses in 2021 in Canada, according to Agriculture and Agri-Food Canada, Animal Industry Division.

Increasing slaughtering activities and establishment of retail chains and supermarkets has made animal meat readily available across North America. Rising demand for sustainable packaging which keeps meat fresh and offers stable shelf life has accelerated the sales of high barrier fresh meat packaging products.

COVID-19 pandemic hindered the fresh meat packaging production due to lack of raw material used in manufacturing and disruption of supply chain. As majority of raw materials are imported, lockdown and closure of trading routes slowed the production rate.

Market is expected to bounce back post pandemic. Investment in research and development of environment friendly packaging solution will boost the market growth.

Request TOC @ https://www.futuremarketinsights.com/toc/rep-na-1517

Key Takeaways from FMI’s Fresh Meat Packaging Market Study

Ethylene Vinyl Alcohol (EVOH) material segment is expected to grow at more than 4% CAGR owing to its eco-friendly nature and high recyclability.
Modified atmosphere packaging technology is predicted to expand at more than 2.6% CAGR owing to its superior aesthetics and improved shelf life.
7-layer segment will generate the highest revenue followed by 5-layer segment as they offer extended shelf life, protects meat from bacteria like salmonella.
U.S. will account for more than 80% share of the North America market backed by increasing consumption and export of poultry and beef and presence of modern processing infrastructure in the country.

“Rising popularity of fresh processed meat products like hot dogs and rapid expansion of quick service restaurant chains and fast food joints like McDonalds will boost the demand for fresh meat packaging in North America,” says the FMI analyst.

Key Segments Covered in Fresh meat packaging Market Study:

By Packaging Format:

Modified Atmospheric Packaging
Vacuum Skin Packaging
Verteroplasty Packaging
Others

By Material Type:

Polyethylene
Poly vinyl chloride
Bi-axially oriented polypropylene
Polyamide
Ethylene-vinyl alcohol copolymer
Polypropylene
Others

By Layer Type:

Monolayer
3-layer
5-layer
7-layer
9-layer

By Meat Type:

Beef
Pork
Poultry
Others

Key Regions/Countries Covered:

North America
- U.S.
- Canada

More Insights on the Fresh Meat Packaging Market

In its latest report, FMI offers an unbiased analysis of the North America fresh meat packaging market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the market potential in North America, its growth, and scope, the market is segmented on the basis of packaging format (modified atmospheric packaging, vacuum skin packaging, verteroplasty packaging, and others), material type (polyethylene, poly vinyl chloride, bi-axially oriented polypropylene, polyamide, ethylene-vinyl alcohol copolymer, polypropylene, and others), layer type (monolayer, 3-layer, 5-layer, 7-layer, and 9-layer), meat type (beef, pork, poultry, and others), across major regions of North America.

Ask An Analyst @ https://www.futuremarketinsights.com/askus/rep-na-1517

https://hackmd.io/@gIcs53uxSgCBwWUrR-iMXQ/BkAKOyriq

https://acatpg.mn.co/posts/24948904?utm_source=manual

https://globalsocials.mn.co/posts/24948906?utm_source=manual

https://faceblox.mn.co/posts/24948907?utm_source=manual

Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Herbal Medicinal Products Market is expected to reach US$ 360.35 Billion by the end of 2031

The herbal medicinal products market revenue totaled US$ 171.62 Bn in 2021, according to Future Market Insights (FMI) study. The overall sales of herbal medicinal products is expected to reach US$ 360.35 Bn by 2031, growing at a CAGR of 7.7 % for 2021 – 2031.

Government initiatives undertaken around the world, especially in the West to encourage the use of herbal medicine has resulted in the development of mass distribution networks, increasing prescription of homeopathic medications, and demand for Ayurveda treatments.

According to a recent study by Future Market Insights (FMI), these factors have proven crucial at enabling growth in the herbal medicinal market. Sales of herbal medicines are expected to top US$ 171.62 Bn in 2021, at a CAGR of 7.7% during the forecast period (2021-2031).

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2722

Soaring concerns pertaining to adverse effects of allopathic medicines has been causing gradual shift of preference in favor of traditional herbal medicines. These medicines are often used for treatment of ailments including neurological diseases, cough, cold & flu, sexual problems, feminine problems, and metabolic diseases. Herbal remedies are used to maintain health and systemic balance, of body functions without sedation and side effects.

In 2015, La Political de Attention Integral a la Saluda Indigene de FUNASA of Brazil promoted traditional systems of health of indigenous communities. Similarly, the government has recognized homeopathic medicines as a medical specialty and included it in the National Health System. Brazil is currently home to around 12,000 homeopathic physicians and 300 homeopathic pharmacists.

As per the World Health Organization (WHO), around 60% of the world’s population is reliant on herbal medicines for primary health care needs. In developing countries, this number accounts for up to 80%. Around 75% of such sales are made through direct user-pharmacy contacts. The growing trend of online pharmacies and mail-on-order purchases drives the demand for self-medication.

The global geriatric population is rapidly expanding with higher life expectancy rates. According to the World Bank, in 1990, the average mortality among geriatric world population was around 6 %, which increased to 9.5% in 2020. The prevalence of chronic diseases associated with an aging population portrays the need for effective medications.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-2722

Key Takeaways from Protein A Resin Study:

Demand for Chinese medicines is expected to grow at 8.2% CAGR through 2031, owing to investments into promotion of traditional Chinese medicine.
Retail pharmacies are projected to capture over 23% of the global market by 2031. This is attributed to availability of consumer health products.
Europe is the largest revenue-generating region for herbal medicinal products, with Germany accounting for nearly 18% of the regional market in 2031.
China holds the leading position in East Asia, and is expected to account for over 49% of the market in 2031.
South Asia is the third most lucrative market with India accounting for over 74% of the share in 2031.
Competitive Landscape

Manufacturers of herbal medicine are primarily aiming to carry out strategic expansions and filing patents to consolidate growth in a competitive market.
For Instance, In Oct 2020, the Arkopharma SA filled a patent for the Arkodigest® No Reflux 100% natural composition to improve digestion.
In November 2020, Mountain Rose Herbs purchased the Phoenix Industrial Park in Eugene, with 205,000 square feet of operational space and a 12-acre campus, as a part of business expansion strategy to develop it into green space.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2722

The key market players covered by FMI include :

Blackmores Limited,
Sanofi-Aventis Healthcare PTY Ltd.,
Arkopharma SA,
Nutraceutical Corporation,
STADA Arzneimittel AG,
Himalaya Global Holdings Ltd,
Integria Healthcare,
Boiron Group,
Young Living Essential Oils,
Mountain Rose Herbs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Vascular Closure Device (VCD) Market will reach US$ 963 million value towards the end of 2022 | FMI

Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade. With rising incidence of cardiac disorders, new and improved cardiovascular treatments have been developed, which have further propelled the adoption of vascular closure devices (VCDs). According to a recently-published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of 5.9%, and reach US$ 963 million over the forecast period, 2017-2022. Compared to manual compression techniques, vascular closure devices play a key role in lowering undue complications such as bleeding.

However, increasing use of transradial arterial access, the continued requirement for post-procedure bed rest, significant costs, and device deployment complexities are observed as key deterrents for adoption of vascular closure devices. The use of VCDs is also anticipated to be influenced by a significant increase in the number of outpatient PCI procedures and the desire of patients to avoid arterial cut-down procedures. According to the report, hospitals will be the largest end-users of vascular closure devices in the next five years. By the end of 2022, over US$ 600 million revenues are anticipated to be procured globally from the end-use of vascular closure devices in hospitals.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1809

North America to Exhibit Steadfast Adoption of Vascular Closure Devices

A regional analysis provided in the report reveals North America as the largest market for vascular closure devices. The region is anticipated to remain at the forefront of global expansion of vascular closure devices market through 2022. Robust healthcare marketplaces in the US, coupled with consumer lifestyles that have surged the incidence of cardiac disorders, will continue to boost North America’s presence in the global vascular closure devices market. The report also projects that Asia-Pacific excluding Japan (APEJ) region will register fastest growth in its vascular closure devices market, and rake over US$ 145 million by the end of 2022.

Clip-based VCDs to Register 6% CAGR through 2022

A key insight from the report reveals that the demand for clip-based vascular closure devices will be relatively higher than compression devices and haemostasis pads. Despite the latter being top-selling products in the global vascular closure devices market, clip-based VCDs are expected to outpace them in terms of demand over the next five years. From medical standpoint, many surgeons prefer VCDs designed with active approximators that can physically close the arteriotomy by using nitinol clips. These metallic clips can also restrict MRI scanners from capturing the unnecessary structures which are immediately adjacent to the arteriotomy. These clip-based VCDs can boost procedural efficiency as well as post-procedural diagnostics for a wide range of cardiovascular treatments.

Companies to Watch

Companies namely, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc, Cardiva Medical, Inc., Arstasis, Inc., Chitogen, Inc., Marine Polymer Technologies, Inc., Essential Medical, Inc., Scion Cardio-Vascular, Inc., Morris Innovative, Inc., Tricol Biomedical, Inc., Vascular Closure Systems, Inc., and TZ Medical, Inc. are profiled in the report as key players in the global vascular closure devices market. In the near future, several manufacturers of vascular closure devices will be focusing on reducing the existing drawbacks of using VCDs, which include extended hospitalisation, high morbidity risks, and the need for administering antibiotics. Some companies will also be focusing on advancing their umbrella on VCD technologies and improving the quality of life for patients being treated through vascular closure devices.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1809

Market Taxonomy The taxonomy of global vascular closure device market has been concisely illustrated in the table below:

Region

North America
Latin America
Europe
Japan
APEJ
MEA

Product Type

Haemostasis Pads
Compression Devices
Clip
Plug
Suture
Others

End User

Hospitals
Ambulatory Surgical Centres
Independent Catheterisation Labs

About FMI:

Microscope Digital Cameras Market to reach a value of around US$ 1.2 Billion by the end of 2027 | FMI

Valuable insights on the global scenario of microscope digital cameras have been presented systematically in a recently carried out research on microscope digital cameras market by Future market Insights in its new publication titled “Microscope Digital Cameras: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. This research focusses on key players, trends, growth drivers, opportunities, developments and restraints across several key geographies of North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA). On the basis of a structured research process and taking into consideration the past and present scenario, forecasts are provided in the research report from the period 2017 to 2027, a ten year forecast model, across each and every segment of the market.

Global Microscope Digital Cameras Market: Competition Analysis

The global microscope digital cameras market has profiled key players such as Danaher Corporation, Nikon Corporation, Roper Technologies, Inc., Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Basler AG, Guangzhou Micro-shot Technology Co., Ltd., BMS microscopes bv., and Euromex Microscopen bv.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3523

Global Microscope Digital Cameras Market: Forecast Highlights

According to the insightful market survey on microscope digital cameras, the global microscope digital cameras market is anticipated to grow at a high pace to register a robust 9.2% CAGR during the assessment period. During the 2017-2027 period, the global market is estimated to reach a market evaluation of about US$ 1.2 Bn by the end of 2027.

Global Microscope Digital Cameras Market: Segmental Insights

Global microscope digital cameras market is segmented by product type (biological microscope cameras, industrial microscope cameras), by sensor type (CMOS, CCD), by mount type (C mount, eyepiece mount/ocular mount), by end user (hospitals, research laboratories, pharmaceutical and biotechnology industries, clinics) and by region.

North America regionshows high lucrativeness and is expected to dominate the global microscope digital cameras market during the forecast period with respect to high market valuation. This region is estimated to grow at a stellar growth rate to reach a valuation of about US$ 353.3 Mn by 2027 end. Japan region is expected to grow at the highest rate, a shade higher than North America to register a 10.3% CAGR throughout the forecast period
Biological microscope cameras segment by product type, is projected to register a higher CAGR of 9.3% during the forecast period and is more likely to lead the global market by product type in terms of high market value
By mount type, C mount segment shows high potential as it grows at a comparatively high rate to reach a 9.4% CAGR and is likely to show dominance over eyepiece mount/ ocular mount segment. The C mount segment shows a market value almost seven times that of the eyepiece mount/ ocular mount segment
The CCD segment by sensor typeis expected to lead the market with a high value share. The CMOS segment shows high growth rate to register a stellar CAGR of 11.3% throughout the assessment period
By end user, research laboratories (clinical and non-clinical) segment dominates the global market with a valuation of about US$ 645.7 Mn in 2027, growing at a robust growth rate. With respect to growth rate, the pharmaceutical and biotechnology industries segment is projected to register the highest CAGR of 9.7% during the period of forecast 2017-2027

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3523

Global Microscope Digital Cameras Market: Dynamics

Various factors favour the growth of the global microscope digital cameras market and the impact of these factors changes from region to region. Diverse application of microscope imaging technology, rising preference for CMOS and CCD, increasing penetration of international players through mergers, growing partnerships for direct distribution, higher spending on academic research along with focus on digital pathology, emergence of digitalization in the life science research, rising demand for microscopy cameras in scientific applications, new product innovations and launches, advancements in microscope digital cameras and rising laboratory automation are supporting the growth of the global microscope digital cameras market. However, factors such as premium pricing limiting market penetration ability, limited manufacturing facilities for microscope cameras, high equipment cost and entry barriers for small players to enter the consolidated market are posing growth restraints to the growth of the global microscope digital cameras market.

Market Taxonomy By Product Type

Biological Microscope cameras
Industrial Microscope Cameras

By Sensor Type

CMOS
CCD

By Mount Type

C Mount
Eyepiece Mount/Ocular Mount

By End User

Hospitals
Research laboratories
Pharmaceutical and Biotechnology Industries
Clinics

By Region

North America
Western Europe
Eastern Europe
APEJ
Japan
Latin America
MEA

About FMI:

Automated Breast Ultrasound Systems Market Growth, Latest Trends, Top Players, Competition, Technological Advancements, Outlook and Forecast 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.
The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.
Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany
Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.
India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.
Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-606

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-606

Key Segments Covered

By End User

Hospitals
Diagnostic Imaging Laboratories

America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Western Europe
- EU-5
- BENELUX (Belgium, Netherlands, Luxembourg)
- NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
- Rest of Europe
Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
Japan
APEJ (Asia Pacific excluding Japan)
- China
- India
- ASEAN Countries
- Australia & New Zealand
- Rest of APEJ
MEA
- GCC Countries
- South Africa
- Israel
- Turkey
- Iran
- Rest of Middle East & Africa

About FMI:

Hyaluronic Acid Products Market to Witness Excellent Revenue Growth, Overview, Emerging Trends and Forecast by 2030

[284 Pages Report] Hyaluronic acid products have been gaining the momentum backed by massive use in therapies intended at the treatment of osteoarthritis, vesicoureteral reflux (VUR), and dry eye diseases, besides diverse aesthetic applications. Future Market Insights (FMI) in a new study has forecast the global market for hyaluronic acid products to surpass US$ 2.7 Bn by 2021.

As a result, the demand of minimally invasive treatment for diseases such as osteoarthritis and VUR stemmed. Manufacturers are introducing advanced intra-articular hyaluronic acid injections (IAHA) injections for the minimal invasive pain management with minimal pain, short recovery time and shorter hospital stay period.

The rising demand of the minimally invasive treatment for the pain management of osteoarthritis and other chronic ailments have pushed the key players to introduce innovative hyaluronic acid products into the market. The conventional treatment regime for chronic diseases was often invasive, involving certain amount of risk for patients with medical-comorbidities. These treatment methods often resulted in long hospital stays.

FMI has forecast dermal fillers to remain key application segment, accounting for over 35% of sales in 2021. The dermatological application of hyaluronic acid also has seen surge with the introduction of advanced dermal fillers, masks, and serums for application in restorative therapy and wrinkle augmentations.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-486

Major Key Players:

Anika Therapeutics, Inc.
Fidia Farmaceutici S.p.A.
Sanofi
Ferring B.V.
Viatris Inc.
Croma-Pharma
Seikagaku Corporation
Zimmer Biomet
Lifecore Biomedical, LLC
LG Chem
Bioventus LLC
Smith & Nephew plc
Shanghai Jingfeng Pharmaceutical Co., Ltd.
Nestle (Galderma)
Bausch Health Companies Inc. Companies Inc. (Salix Pharmaceuticals, Inc.)
Allergan Plc.

The global hyaluronic acid products market is set to expand its scope in the forecast period, as a result of rising prevalence of chronic diseases and expanding geriatric population. In addition to this, the rising demand for minimally invasive therapies and advancing aesthetic procedures and products are propelling the growth of the market.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-486

Key Takeaways from Hyaluronic Acid Products Market Study

The hyaluronic acid products market will expand at a CAGR of 6.1% between 2020 and 2030
The U.S. will emerge as one of the leading markets, accounting for over 73% of sales in North America
The U.K. will remain one of the key markets within Europe, registering 7.7% Y-o-Y growth in 2021
The demand for Germany and France will continue rising at a positive rate
Japan will emerge as a leading market in East Asia, followed by China and South Korea

Who is winning?

Manufacturers in the hyaluronic acid products market are focusing on advanced IAHA injections, dermal filler, and other products. The delivery of hyaluronic acid to the target site has been made effective, precise, and minimally invasive. This is intended at ensuring more effective pain management for various chronic and inflammatory diseases such as osteoarthritis. Many manufacturers are focused on developing advanced, effective and affordable IAHA injections that come with advanced targeted delivery and minimal invasiveness.

For instance, Synvisc by Sanofi is effective for osteoarthritis pain. The advanced range of dermal filler launched by Galderma of Nestlé, named Restylane covers a wide spectrum dermal application for volume restorative therapy and Restylane Lyft is indicated for the wrinkle augmentation of the backside of the hand.

Valuable Insights into Hyaluronic Acid Products Market

Future Market Insights, in its new report, provides an unbiased analysis of the hyaluronic acid products market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2030. The study divulges compelling insights into the hyaluronic acid products market based on product type (single cycle injection, three cycle injection, five cycle injection), application (osteoarthritis, ophthalmic, dermal fillers, and vesicoureteral reflux), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and specialty clinics). Regionally the market covers North America, Europe, Latin America, East Asia, South Asia, Oceania, and the Middle East and Africa.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-486

Hyaluronic Acid Products Market by Category

Product

Single Cycle Injection Products
Three Cycle Injection Products
Five Cycle Injection Products

Application

Osteoarthritis
Ophthalmic
Dermal Fillers
Vesicoureteral Reflux

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Speciality Clinics

About FMI:

Lab Automation Market is likely to grow at a CAGR of 9.6% through 2027 | FMI

Dynamics of the Global Lab Automation Market

Increasing incidences of life threatening diseases and injuries have led to increasing diagnostics procedures, worldwide. It is estimated that, the direct and indirect costs of diagnosis will increase over a period of time. The rising research and development activities in the field of molecular and genetics, biochemistry, microbiology, and immunology have also boosted the demand for accurate and cost saving facilities. To develop cost-effective and cost-efficient medical devices and lab automation services, various governments in developed countries are actively funding R&D activities. For instance, the New South Wales (NSW) government in Australia, has provided a medical devices fund of around US$ 8.0 million in 2017-2018 to help encourage and support investments in the development and commercialization of medical devices, related technologies, and services.

According to a recent market report published by Future Market Insights titled, ‘Lab Automation Market – Global Industry Analysis and Opportunity Assessment, 2017–2027’, the global lab automation market is expected to be valued at US$ 1,219.4 Mn in 2017, and is expected to register a CAGR of 9.6% from 2017 to 2027. Lab automation is increasingly being installed by various end users such as pharmaceutical companies, hospitals and diagnostic centers, educational institutions, contract research organizations (CROs), and research institutes. There has been an increase in the usage of lab automation components in hospitals and diagnostic centers, due to an increase in the demand for biochemistry devices.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-394

Favourable government policies for start-ups enable companies to develop cost-effective healthcare solutions in the lab automation market. Over the last few years, government authorities in Asia Pacific and Middle East and Africa are encouraging start-up companies as well as MNCs to boost industrial growth in the healthcare and medical device industries. Major players in the in-vitro diagnostics market can capitalize on the economies of scale to strengthen their position in the market.For instance, India, a developing country in the Asia Pacific region, has announced new policies for attracting MNCs as well as start-up companies across domains, including medical device manufacturing. According to the policies, start-up companies in India are exempt from tax for the first three years after establishment, and patent protection costs are subsidized. Thus, favourable government policies in developing countries are expected to drive overall the lab automation devices and services market.

However, the complex integration of lab tools hinders the demand for lab automation solutions. Lab professionals are focusing on the better utilization of test tools, consolidating various resources and deploying effective lab tools across all platforms. Interconnecting various platforms across the lab is a very critical task, and needs advanced PR-PR open-source high-level robot programming language as a cross-platform laboratory automation system, which may lead to complexity and a variety of test configurations, and restrain the growth of the lab automation market over the forecast period.

Global Lab Automation Market: Key Players

Some of the key competitors in the lab automation market are Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, and Transcriptic, Inc.

These key players are constantly focusing on product innovation and geographical expansions to sustain their market presence and increase revenue generation by developing various types of solutions and delivering outstanding offerings to several end users.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-394

Key Segments:

Component Type

Devices
- Biochemistry Devices
- Molecular Devices
- Hematology Devices
- Immunology Devices
- Microbiology Devices
- Others

Software

Scheduling Software
Momentum Integration Software

Application

Life Sciences Research and Development
Drug Discovery
Diagnostics

End User

Pharmaceutical Companies
Hospitals and Diagnostic Centers
Educational Institutions
Contract Research Organizations (CROs)
Research Institutes

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-394

Key Regions

North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Rest of Latin America
Western Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
APEJ
- China
- India
- Australia & New Zealand
- ASEAN
- Rest of APAC
Japan
MEA
- GCC Countries
- Turkey
- South Africa
- North Africa
- Rest of MEA

About FMI:

Respiratory Inhaler Devices Market to grow at 4.4% CAGR through 2030 | FMI

Global respiratory inhaler device shipments are likely to grow at over 4% in 2021, as the medical device industry makes a gradual recovery. Innovation in smart inhaler technologies is likely to be a key focus area, but manual inhalers will still account for 90% of total demand. This stark contrast reflects the status-quo in the global medical device industry, where realization of new investment and bottom-lines are concurrent.

[250 Pages Report] The rising prevalence of respiratory disorders has necessitated innovation in manufacture of respiratory inhalers. The demand for better precision in drug delivery is enabling broader adoption of Respiratory Inhaler Devices, especially among patients of asthma and chronic obstructive pulmonary diseases (COPD). Steady growth is expected to continue as favorable reimbursement policies by governments create a conducive environment around the world.

Global demand for respiratory inhaler devices continues to be driven by rising prevalence of COPD and asthma. According to the World Health Organization (WHO), nearly 251 million cases of chronic obstructive pulmonary disease (COPD) were reported worldwide in 2016 and nearly 339 million people were estimated to have asthma in the same year. Coupled with this, surging healthcare spending has been creating lucrative prospects for growth of the market.

Market players also are focusing on novel inhalation technologies to ascertain drug delivery to lungs. Spurred by these factors, the global market for respiratory inhaler devices is expected to report surging sales.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-493

Smart Inhaler Technology Touted as a Major Breakthrough

Smart inhalers have been touted as a disruptive technology, and it remains a key focus area for manufacturers. Smart inhalers can signal patients if their overusing any medication, warning them against poor management of the condition. The technology is touted as a major breakthrough in the healthcare sector and one that is expected to enable growth in the respiratory inhaler devices market in the coming years.

Several studies already are underway gauging the potential of these development. For instance, My AirCoach, which is an EU-funded multi-institutional research project, aims at assessing how novel mobile health technologies, including smart inhalers, can help offering improved asthma control.

With myriad of developments underway, respiratory inhaler device shipments are likely to gain traction through 2030. FMI’s report offers a comprehensive analysis on how growth will unfold. Some of the key takeaways from the report are:

Dry powder inhalers remain the most lucrative category
Manually operated inhaler devices will remain preferred choice among available technologies
Respiratory inhaler devices sales surging to offer improved asthma control and management
US to remain a highly lucrative market for respiratory inhaler devices, however, growth in East Asia is expected to accelerate at a higher pace

“Some of the leading players are working on technologies that would enable monitoring and correction of inhalation techniques in the near future. They are developing smart inhalers that will use the Bluetooth technology to monitor inhaler use in patients. While several developments are underway, industry experts are cautiously examining the potential of smart inhalers to ensure all potential concerns pertaining to the novel technologies are ironed out. However once launched, smart technology can help the market gain momentum at accelerated pace in the near future,” said a lead analyst at FMI.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-493

Some of the leading companies are focusing on innovations and product launches to gain competitive advantage. There also are companies trying to capitalize on opportunities across high potential markets. For instance, Zydus Cadila has announced launching India’s first pressurized Metered Dose Inhaler (pMDI) – Forglyn pMDI with a combination of Long Acting Beta Agonist (LABA) and Long Acting Muscarinic Antagonist (LAMA) for COPD patients in October 2020.

In 2019, Lupin announced launching “ADHERO,” which is a connected smart device for metered dose inhalers and promises to ensure improved adherence to inhalation therapy for COPD treatment.

In the latest report by Future Market Insights, we offer an unbiased analysis of the global respiratory inhaler devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (dry powder inhaler, metered dose inhaler, and nebulizer), technology (manually operated inhaler devices and digitally operated inhaler devices), disease indication (asthma, COPD, pulmonary arterial hypertension, other respiratory diseases), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Key Segments

Product

Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
- Compressed Air Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers

Technology

Manually Operated Inhaler Devices
Digitally Operated Inhaler Devices

Disease Indication

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Arterial Hypertension
Others

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/493

Region

North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa (MEA)
Oceania

About FMI:

Vascular Access Catheters Market Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2027

With healthy CAGR of 5.5%, the global vascular access catheters market is likely to grow with an impressive growth rate during the projected period. The primary reasons for this remarkable growth is shift towards value-based healthcare model, increasing global healthcare spending and global manufacturer’s focus on emerging market. According to the new report “Vascular Access Catheters Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027) that is published by Future Market Insights, global vascular access catheters market to grow from US$ 2,365.3 Mn in 2017 to US$ 4,042.8 Mn by 2027 end. This represents CAGR of 5.5% over the projected period of 10-years. The global vascular access catheters market for represents absolute $ opportunity of US$ 118.9 Mn in 2018 over 2017 and incremental opportunity of US$ 1,677.5 Mn between 2017 and 2027.

Request Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5327

Global Vascular Access Catheters Market: Drivers

Increased precision of PICC and CVC placement with tip location devices
Improved Reimbursement policies
Preference by surgeons, anaesthesiologists & interventional radiologists
Increasing number of diseases with PICC application
Distribution and collaboration agreement to increase product reach
Introduction of Innovative products
Product availability through appointing distributors
Increasing forward integration
Introduction of new PICC having anti-thrombogenic property
Radiopaque catheter material or marking

Global Vascular Access Catheters Market: Forecast by Product

On the basis of product type, the global vascular access catheters market is segmented into CVC Catheters, Implantable Port, Dialysis Catheters and PICC Catheters. CVC catheters dominated the global market in 2016, and is expected to continue to do so. Also, increasing approvals for new products in the hemodialysis and peritoneal dialysis segment would further increase the adoption.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5327

Global Vascular Access Catheters Market: Forecast by End Use

By end use the global market for vascular access catheters market is segmented into hospitals, ambulatory surgical centres and specialty clinics and others. Hospital is expected to be the most lucrative among all end users of vascular access catheters products, with attractiveness index of 2.7, while specialty clinics and others are expected to be the least attractive end users of vascular access catheters, with market share index of 0.8.

Global Vascular Access Catheters Market: Forecast by Design

Design segment consists of single lumen, double lumen, and multiple lumen. Double Lumen, dominated the vascular access catheters market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Double lumen catheters is expected to be the most lucrative among property segment, with attractiveness index of 2.1.

Global Vascular Access Catheters Market: Forecast by Property

The property segment of the global vascular access catheters market includes antimicrobial catheter and non-anti-microbial catheter. Non Anti-microbial catheter, dominated the vascular access catheters market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Non Anti-microbial Catheter is expected to be the most lucrative among Property segment, with attractiveness index of 1.5.

Global Vascular Access Catheters Market: Forecast by Region

This report has covered seven regions namely, North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA. North America vascular access catheters market accounted for largest revenue share of 44.6% in 2016. Western Europe is expected to experience highest CAGR of 5.8% over 2017–2027, primarily due to increase in chronic kidney dialysis & cancer. Also rising healthcare reach in untapped markets may spur revenue growth during the forecast period.

Global Vascular Access Catheters Market: Key Players

Some of the key players operating in the global vascular access catheters market are Angio Dynamics, C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, Kimal Healthcare, Comed B.V., Medtronic Plc, Smiths Medical, Vygon (UK) Ltd, Becton, Dickinson and Company, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Incorporated and Fresenius Kabi AG.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5327

Market segmentation By Region

North America
Latin America
Western Europe
Eastern Europe
APEJ
MEA
Japan

By Product Type

CVC Catheters
Dialysis Catheters
PICC Catheters
Implantable Port

By Design

Single Lumen
Double Lumen
Multi Lumen

By End Use

Hospitals
Ambulatory
Surgical Centres
Specialty Clinics & Others

By Property

Antimicrobial Catheter
Non Anti
Microbial Catheter

About FMI: